Paper39187807
Prediction of PD-L1 and Ki-67 status in primary central nervous system diffuse large B-cell lymphoma by diffusion and perfusion MRI: a preliminary study.
Zhou X and 6 others. BMC Med Imaging, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Prediction of PD-L1 and Ki-67 status in primary central nervous system diffuse large B-cell lymphoma by diffusion and perfusion MRI: a preliminary study. Papers, record 39187807. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39187807
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prediction of PD-L1 and Ki-67 status in primary central nervous system diffuse large B-cell lymphoma by diffusion and perfusion MRI: a preliminary study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ki-67 Antigen | Major topic |
| B7-H1 Antigen | Major topic |
| Diffusion Magnetic Resonance Imaging | Major topic |
| Lymphoma, Large B-Cell, Diffuse | Major topic |
| Central Nervous System Neoplasms | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Retrospective Studies | |
| Aged | |
| Adult | |
| Aged, 80 and over | |
| Magnetic Resonance Angiography | |
| ROC Curve |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. JAT210090 | Scientific Research Project from the Education Department of Fujian Province | PubMed | ||
| No. 2021J01706 | Natural Science Foundation of Fujian Province | PubMed | ||
| No. 2021Y9093 | Joint Funds for the Innovation of Science and Technology, Fujian Province | PubMed | ||
| No. 22SCZZX023 | Fujian Provincial Finance Project | PubMed |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21818113 | Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. | Leukemia | 2011 | https://conductscience.org/library/papers/21818113 | PubMed |
| 2 | 27269947 | Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27269947 | PubMed |
| 3 | 30917792 | The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis. | BMC Cancer | 2019 | https://conductscience.org/library/papers/30917792 | PubMed |
| 4 | 19384938 | Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. | Am J Hematol | 2009 | https://conductscience.org/library/papers/19384938 | PubMed |
| 5 | 29383521 | Standard diffusion-weighted, diffusion kurtosis and intravoxel incoherent motion MR imaging of sinonasal malignancies: correlations with Ki-67 proliferation status. | Eur Radiol | 2018 | https://conductscience.org/library/papers/29383521 | PubMed |
| 6 | 36060584 | Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and 18F-FDG PET. | Quant Imaging Med Surg | 2022 | https://conductscience.org/library/papers/36060584 | PubMed |
| 7 | 25943068 | Programmed cell death-1 inhibition in lymphoma. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25943068 | PubMed |
| 8 | 27742108 | Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice. | Magn Reson Imaging Clin N Am | 2016 | https://conductscience.org/library/papers/27742108 | PubMed |
| 9 | 31597366 | Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31597366 | PubMed |
| 10 | 29246587 | Endometrial carcinoma: diffusion-weighted imaging diagnostic accuracy and correlation with Ki-67 expression. | Clin Radiol | 2018 | https://conductscience.org/library/papers/29246587 | PubMed |
| 11 | 9397461 | Primary central nervous system lymphoma: radiologic-pathologic correlation. | Radiographics | 1997 | https://conductscience.org/library/papers/9397461 | PubMed |
| 12 | 25482239 | PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25482239 | PubMed |
| 13 | 21098200 | Correlation of diffusion and perfusion MRI with Ki-67 in high-grade meningiomas. | AJR Am J Roentgenol | 2010 | https://conductscience.org/library/papers/21098200 | PubMed |
| 14 | 37133522 | Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI. | Eur Radiol | 2023 | https://conductscience.org/library/papers/37133522 | PubMed |
| 15 | 32809860 | Comparison of Conventional, Diffusion, and Perfusion MRI Between Low-Grade and Anaplastic Extraventricular Ependymoma. | AJR Am J Roentgenol | 2020 | https://conductscience.org/library/papers/32809860 | PubMed |
| 16 | 31705255 | DWI and IVIM are predictors of Ki67 proliferation index: direct comparison of MRI images and pathological slices in a murine model of rhabdomyosarcoma. | Eur Radiol | 2020 | https://conductscience.org/library/papers/31705255 | PubMed |
| 17 | 34976829 | Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by 18F-FDG PET/CT Radiomics and Clinicopathological Characteristics. | Front Oncol | 2021 | https://conductscience.org/library/papers/34976829 | PubMed |
| 18 | 36428726 | Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36428726 | PubMed |
| 19 | 26239088 | Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. | Blood | 2015 | https://conductscience.org/library/papers/26239088 | PubMed |
| 20 | 28356247 | PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma. | Blood | 2017 | https://conductscience.org/library/papers/28356247 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42168907 | Non-invasive prediction of B-cell lymphoma-2 and Ki-67 expression in primary central nervous system lymphoma using whole-tumor histogram analysis of diffusion weighted imaging, diffusional kurtosis imaging and intravoxel incoherent motion. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42168907 | PubMed |
| 42063134 | Prediction of relapsed/refractory primary central nervous system lymphoma using pre-chemotherapy ITSS grade on SWI and pre-/post-chemotherapy ADC parameters on DWI. | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42063134 | PubMed |
| 41959915 | Case Report: Cerebellar ALK+ ALCL: diagnostic challenges and therapeutic innovation. | Front Oncol | 2026 | https://conductscience.org/library/papers/41959915 | PubMed |
| 41844850 | The value of time-dependent diffusion MRI in nasopharyngeal carcinoma: correlation with prognostic factors. | Eur Radiol | 2026 | https://conductscience.org/library/papers/41844850 | PubMed |
| 41459535 | Evaluation of programmed cell death ligand-1 expression in primary central nervous system lymphoma using whole-tumor histogram analysis of multiparametric MRI: implications for immunotherapy selection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459535 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39187807
GET https://conductscience.org/api/papers/v1/39187807/references?page=2